Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1959 Sep 5;2(5148):336–341. doi: 10.1136/bmj.2.5148.336

Treatment of Haemolytic Disease of the Newborn Due to Rh-immunization*

A Jouvenceaux, C P Brizard, Mme D Michaud, L Revol
PMCID: PMC1991561  PMID: 14407999

Full text

PDF
336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABELSON N. M., BOGGS T. R., Jr Spectrophotometric absorption patterns in erythroblastosis fetalis. AMA Am J Dis Child. 1953 Oct;86(4):461–462. [PubMed] [Google Scholar]
  2. AKERREN Y. Prolonged jaundice in the newborn associated with congenital myxedema; a syndrome of practical importance. Acta Paediatr. 1954 Sep;43(5):411–425. doi: 10.1111/j.1651-2227.1954.tb04049.x. [DOI] [PubMed] [Google Scholar]
  3. ALLISON A. C., MOORE T., SHARMAN I. M. Haemolysis and haemoglobinuria in vitamin-E deficient rats after injections of vitamin-K substitutes. Br J Haematol. 1956 Apr;2(2):197–204. doi: 10.1111/j.1365-2141.1956.tb06828.x. [DOI] [PubMed] [Google Scholar]
  4. BEVIS D. C. The antenatal prediction of haemolytic disease of the newborn. Lancet. 1952 Feb 23;1(6704):395–398. doi: 10.1016/s0140-6736(52)90006-8. [DOI] [PubMed] [Google Scholar]
  5. BIALKIN G., HARRIS L. Clinical kernicterus and congenital hypothyroidism. N Y State J Med. 1958 Jan 1;58(1):101–103. [PubMed] [Google Scholar]
  6. BONGIOVANNI A. M., EBERLEIN W. R., WESTPHAL M., BOGGS T. Prolonged turnover rate of hydrocortisone in the newborn infant. J Clin Endocrinol Metab. 1958 Oct;18(10):1127–1131. doi: 10.1210/jcem-18-10-1127. [DOI] [PubMed] [Google Scholar]
  7. BOUND J. P., TELFER T. P. Effect of vitamin-K dosage on plasma-bilirubin levels in premature infants. Lancet. 1956 May 19;270(6925):720–722. doi: 10.1016/s0140-6736(56)90748-6. [DOI] [PubMed] [Google Scholar]
  8. CROSSE V. M., MEYER T. C., GERRARD J. W. Kernicterus and prematurity. Arch Dis Child. 1955 Dec;30(154):501–508. doi: 10.1136/adc.30.154.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DE BRUIJNE J. I., LIEM KHE HOO, VAN CREVELD S. Clotting factors in haemolytic disease of the newborn. II. Thrombocytopenia after replacement transfusion. Etudes Neonatales. 1956 Sep;5(3):109–116. [PubMed] [Google Scholar]
  10. FLAMAND CHRISTENSEN J. Prolonged icterus neonatorum and congenital myxedema. Acta Paediatr. 1956 Jul;45(4):367–371. doi: 10.1111/j.1651-2227.1956.tb06884.x. [DOI] [PubMed] [Google Scholar]
  11. FURMAN R. A., HELLERSTEIN H. K., STARTZMAN V. V. Electrocardiographic changes occurring during the course of replacement transfusions. J Pediatr. 1951 Jan;38(1):45–50. doi: 10.1016/s0022-3476(51)80085-4. [DOI] [PubMed] [Google Scholar]
  12. GAUCHERAND J., REVOL L., JOUVENCEAUX A. A propos de deux sauvetages acrobatiques de maladies hémolytiques du nouveau-né; plaidoyer en faveur de l'accouchement prématuré provoqué. Montp Med. 1952 Nov;41-42(9):1039–1043. [PubMed] [Google Scholar]
  13. GRODSKY G. M., CARBONE J. V., FANSKA R. Enzymatic defect in metabolism of bilirubin in fetal and newborn rat. Proc Soc Exp Biol Med. 1958 Feb;97(2):291–294. doi: 10.3181/00379727-97-23719. [DOI] [PubMed] [Google Scholar]
  14. GUSTAFSON J. E. Electrocardiographic changes in exchange transfusions. J Pediatr. 1951 Nov;39(5):593–596. doi: 10.1016/s0022-3476(51)80181-1. [DOI] [PubMed] [Google Scholar]
  15. JOUVENCEAUX A., BRIZARD C. P., MICHAUD D., REVOL L. Considérations sur la pathogénie et le traitement de la maladie hémolytique du nouveau-né due au facteur Rh: à propos de 330 cas. Pediatrie. 1958;13(5):583–603. [PubMed] [Google Scholar]
  16. JOUVENCEAUX A., REVOL L. A propos du traitement et de la surveillance de la maladie hémolytique du nouveau-né; micro- (et macro-) méthode de dosage de la bilirubine. Presse Med. 1957 Sep 7;65(64):1440–1440. [PubMed] [Google Scholar]
  17. KREVANS J. R., JACKSON D. P. Hemorrhagic disorder following massive whole blood transfusions. J Am Med Assoc. 1955 Sep 17;159(3):171–177. doi: 10.1001/jama.1955.02960200017004. [DOI] [PubMed] [Google Scholar]
  18. LOELIGER A., KOLLER F. Behaviour of factor VII and prothrombin in late pregnancy and in the newborn. Acta Haematol. 1952 Mar;7(3):157–161. doi: 10.1159/000204048. [DOI] [PubMed] [Google Scholar]
  19. MARTMER E. E., CORRIGAN K. E., CHARBENEAU H. P., SOSIN A. A study of the uptake of iodine (I-131) by the thyroid of premature infants. Pediatrics. 1956 Apr;17(4):503–509. [PubMed] [Google Scholar]
  20. MEYER T. C., ANGUS J. The effect of large doses of synkavit in the newborn. Arch Dis Child. 1956 Jun;31(157):212–215. doi: 10.1136/adc.31.157.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. OBRINSKY W., DENLEY M. L., BRAUER R. W. Sulfobromophthalein sodium excretion test as a measure of liver function in premature infants. Pediatrics. 1952 Apr;9(4):421–438. [PubMed] [Google Scholar]
  22. VAN MIDDLESWORTH L. Radioactive iodide uptake of normal newborn infants. AMA Am J Dis Child. 1954 Oct;88(4):439–442. doi: 10.1001/archpedi.1954.02050100441002. [DOI] [PubMed] [Google Scholar]
  23. WALKER W. The changing pattern of haemolytic disease of the newborn (1948-1957). I. Vox Sang. 1958 Jul;3(4):225–242. doi: 10.1111/j.1423-0410.1958.tb03616.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES